ScholarLens Back to search
2017•Modern PathologyOpen access

Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification

Meixuan Chen, Mariacarla Andreozzi, Barbara A. Pockaj, Michael T. Barrett, Idris Tolgay Ocal, Ann E. McCullough, Maria E. Linnaus, James M. Chang, Jennifer H. Yearley, Lakshmanan Annamalai, Karen S. Anderson

Open full text 25 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Comparative genomic hybridization, Fluorescence in situ hybridization, In situ hybridization, Molecular biology, Biology, In situ, Chromosome, Genetics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Development and validation of a novel clinical fluorescence in situ hybridization assay to detect JAK2 and PD-L1 amplification: a fluorescence in situ hybridization assay for JAK2 and PD-L1 amplification — Research Paper | ScholarLens